4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseases
January 03, 2024 08:01 ET
|
Arbor Biotechnologies Inc
Partnership brings together two leaders in next-generation genetic medicines to engineer, co-develop and co-commercialize (50:50 profit share) AAV-delivered CRISPR/Cas-based therapeutics for up to six...
Arbor Biotechnologies Appoints Industry Veteran R. Nolan Townsend to Board of Directors
November 07, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the...
Arbor Biotechnologies Appoints Ajim Tamboli as Chief Financial Officer
August 29, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the...
Arbor Biotechnologies Appoints Deanna M. Petersen as Chief Business Officer
August 07, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the...
Arbor Biotechnologies to Present at the Stifel 2023 Tailoring Genes: Genetic Medicines Day
May 23, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced Devyn Smith,...
Arbor Biotechnologies Announces Presentations at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy
May 02, 2023 16:30 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that three...
Arbor Biotechnologies Appoints Dr. Daniel Ory as Chief Medical Officer
April 12, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic editing medicines, today announced the...
Arbor Biotechnologies to Present at 2023 Cell & Gene Meeting on the Med
April 06, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., April 06, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that Devyn...
Arbor Biotechnologies Announces Expanded Strategic Partnership with Vertex, Now Extending to Precision Gene Editing Using Reverse Transcriptase
January 11, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies (Arbor) today announced the expansion of an existing strategic collaboration covering in vivo genetic medicines by which...
Arbor Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that its Chief...